yes up to greater extant, you are correct.

Blood donation is the noble help to those who do not have a particular group of blood in time. This is full of the perceptional idea that affects blood donors in general. The epidemic COVID-19 makes suspect all of us because the public perceptions are totally different due to this Coronavirus. If someone who frees from Corona can donate blood will hold good for other patients to save the life of the disadvantaged ones. Having done, the proper medical checkup of the body of the blood donator that will not be any problem of donating blood. This is only the wrong perception of people only.

There was report on nervous system transmission from respiratory system, and the time point at which donated blood is taken may matters.

Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients [published online ahead of print, 2020 Feb 27]. J Med Virol. 2020;10.1002/jmv.25728.

https://www.who.int/publications-detail/maintaining-a-safe-and-adequate-blood-supply-during-the-pandemic-outbreak-of-coronavirus-disease-(covid-19)

Donated blood components are critical to the practice of modern medicine. However, clinicians have become too dependent of blood transfusion when underlying haematological deficiency should be addressed appropriately, especially if time permits with many managed without transfusion. Until we fully move from a product focus there will continue to be inappropriate use of altruistically donated blood. The evidence for Patient Blood Management and restrictive red cell transfusion practices for improving patient outcomes and preserving the allogeneic blood donor base is substantial. Patient Blood Management should be standard of care in Perioperative Medicine, especially in elective surgical settings. It worries me that during the COVID-19 pandemic less donor blood is available for urgent and exsanguinating patients as it is being used inappropriately on elective surgical patient in whom PBM is not standard of care. This is an EBM, ethical and economic issue.

I would refer you what the SANB is doing.

https://www.ncbi.nlm.nih.gov/pubmed/31266571

This is worth a look from the SANBS

https://wrap.co/wraps/5b43d5bf-11ac-4da2-b3fe-c8a6b9755928

Good point, James! I echo that

Blood centers' criteria for blood donor eligibility will continue to focus on healthy donors giving blood. Secondly, donors who feel ill within 2 weeks of donating blood should contact the blood center so that their blood can be discarded if it hasn't been used. Eligibility questions to elicit any symptoms of COVID 19 or risk for it should determine whether individuals can donate. If there were a blood donor test, I think that testing the blood for COVID 19 would be optimal, but without that, the questions asked and honesty of the blood donors should protect the blood supply.

Can we use Ultraviolet light for inactivation of the SARS-CoV-2 virus?

DOI: 10.1111/trf.13860

Darnell ME1, Taylor DR.

Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products.

Transfusion. 2006 Oct;46(10):1770-7.

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV

Miriam E.R.Darnell

https://doi.org/10.1016/j.jviromet.2004.06.006

You like to read this that several of us from around the world published this week.

The Essential Role of Patient Blood Management in a Pandemic

A Call for Action

https://journals.lww.com/anesthesia-analgesia/Abstract/publishahead/The_Essential_Role_of_Patient_Blood_Management_in.95719.aspx

COVID 19 rapid guideline: haematopoietic stem cell transplantation. London: National Institute for Health and Care Excellence; 2020 Apr. (NICE guideline; NG164)

https://www.nice.org.uk/guidance/ng164

What is your view towards transfusion under such circumstance?

Effectiveness of convalescent plasma therapy in severe COVID-19 patients Kai Duan, et al Proceedings of the National Academy of Sciences Apr 2020, 202004168;

DOI: 10.1073/pnas.2004168117

In some countries, plasma therapy from people who have previously been infected with SARS-CoV-2 Coronavirus and who have recovered from Covid-19 disease is currently used as a therapeutic therapy for Covid-19 patients. Until the vaccine is created, therapy based on plasma from people who have recovered, i.e. plasma containing multiple antibodies to coronavirus SARS-CoV-2, may be one of the better and more effective therapeutic therapies.

Regards,

Dariusz Prokopowicz

After blood donation, it should be preserved. sample may be ascertained after a period of 28 days to reconfirm the existence of virus. Blood acceptor must ensure whether the blood is free from virus and other contaminations.

The Essential Role of Patient Blood Management in a Pandemic

https://doi.org/10.1213/ANE.0000000000004844

Have a look at this useful RG link.

Article "Because Every Drop Counts": Blood donation during the COVID...